ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OPTI Optibiotix Health Plc

16.50
-0.25 (-1.49%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -1.49% 16.50 16.00 17.00 16.75 16.50 16.75 169,683 14:04:40
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 5.81 15.05M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 16.75p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £15.05 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 5.81.

Optibiotix Health Share Discussion Threads

Showing 26201 to 26225 of 147750 messages
Chat Pages: Latest  1050  1049  1048  1047  1046  1045  1044  1043  1042  1041  1040  1039  Older
DateSubjectAuthorDiscuss
11/7/2017
13:23
BST 27P just might catch you guys up.!

TOM has it down as his share of the year, and even quotes OPTI as a Reynolds stock that has done very well.

Good luck here

pet lover
11/7/2017
13:19
I think Mr 10k is splitting some into 5k's perhaps to increase the selling pressure
onedayrodders
11/7/2017
13:05
It is a curse in a way , but I am right about 80% of the time, and so far today I have been on this one.

Check out who paid the experienced panellists

Then check out what their experience was in

This RNS has no meaning ... it just says what 10 people thought about a taste experience .... and 10 people as a sample size is riduclous.

The market has taken a dim view of it.



Spike_111 Jul '17 - 10:22 - 24777 of 24792 4 1
buywell - you are pathetic!

buywell3
11/7/2017
13:05
It is a curse in a way , but I am right about 80% of the time, and so far today I have been on this one.

Check out who paid the experienced panellists

Then check out what their experience was in

This RNS has no meaning ... it just says what 10 people thought about a taste experience .... and 10 people as a sample size is riduclous.

The market has taken a dim view of it.



Spike_111 Jul '17 - 10:22 - 24777 of 24792 4 1
buywell - you are pathetic!






buywell3 - 11 Jul 2017 - 08:10:01 - 24757 of 24795 OptiBiotix - Better Science, Better Health. Better buy some! - OPTI
What bothers me about this is the lack of institutional investors on board

Plus the company has only 8 employees, and is thus very BOD top heavy

The majority of shareholders are thus Mr and Mrs J Bloggs.

My 60p call nearly got hit .... todays news gives some a chance to bail.

buywell3
11/7/2017
12:55
I'm waiting for news on Tata before I sell in the next few months. Worried about the mad scramble to sell which is going to come.
rickyvee
11/7/2017
12:55
as expected I think we are going to end up red again on another excellent RNS albeit without £'s
onedayrodders
11/7/2017
12:53
anyone worked out what you press to get an order and checkout ?

I cant fathom it out on that website

onedayrodders
11/7/2017
12:37
Good spot Andy! Looks like LP-LDL has replaced AB-LIFE's product for their LDL-Control capsules: From the website: characteristics Reduction of the cholesterol value by up to 36.7% increased cholesterol levels naturally do not have any side effects Lactobact® LDL-Control is able to effectively reduce the cholesterol level in the blood. This results in a positive effect on the entire cardiovascular system, as the risk of developing arteriosclerosis and associated cardiovascular disease is reduced. Lactobact® LDL-Control is a natural preparation with no side effects, which often occur in conventional therapies with cholesterol-lowering drugs. Therefore, it is also recommended for long-term use. The clinical study of the active substance in Lactobact® LDL-Control has shown that the LDL cholesterol level is reduced by more than 36.7% within a period of only 3 months by the regular daily intake of 1 capsule of this preparation. The preparation ensures that more cholesterol is excreted directly through the intestine and does not enter the body's cholesterol circulation. As a result, the concentration of the blood cholesterol and thus also the negative effect on our cardiovascular system is significantly reduced. Through a cholesterol-conscious diet and regular exercise, you can also positively support this process.Ingredients: Ingredients:Maltodextrin, Lactobacillus plantarum LP LDL®, hydroxypropylmethylcellulose (Capsule shell), corn starchAge level:Lactobact® LDL-CONTROL is suitable for all persons from the age of 8.Recommended dosage:1 capsule daily with plenty of liquid.Dosage:1 capsule contains 4 x 109 CFUContent:90 capsules
parob
11/7/2017
12:36
Well,well,well. A big announcement on sugars and the first sales in Germany.
mrjohngalt
11/7/2017
12:27
Cheers Andy

If I'm reading this right then 90 capsules for around £17 is good value and only double what I'm paying for my Simvastatin.

Of course it will need to keep my Cholesterol levels down.

I'm going to speak with my doctor about coming off statins, using LP-LDL and monitoring my cholesterol levels.

I'll keep you posted.

onedayrodders
11/7/2017
12:25
what's the good of it, re 24787 to people here, get it in the shops in UK and Asia and USA as well as Germany. Can now sell a few at 63.2 and forget 67, top ups available at 64.2.
neftanikoff
11/7/2017
12:20
See OPTI and the perma bulls still spouting the same jam tomorrow BS.I've come to the conclusion that the science here is not as ground breaking as first envisaged. Similar products already in a saturated market and it's all jam tomorrow BS.Also no real appetite for companies products.No real revenue generating products No demand from II investors.Even the perma bulls will wake up soon.By then it will be too late.Just another fluff AIM company.AIMHO
talkingtrade
11/7/2017
12:04
LP-LDL launched and available to buy at HLH:

www.hlh-biopharma.de/produkte/darmgesundheit/lactobact-ldl-control.php

andyhayward1990
11/7/2017
11:50
I personally have got to sell some opti shares within the next 2 months for personal reasons and was (there is that word again) HOPING to get at least 85p and was fully expecting this price in view of what was i expecting, well some big orders with detail along withpartner news and sbtx share distribution news and considering it was 85p on April 1st and Tom W was merrily forecasting over 100p by Easter and even the company were talking about exciting things were happening and contracts being drafted and 30 companies showing interest. At the moment, with lack of news on the subjects that i had thought i was going to hear about, i somehow think that i may have been let up the gareden path and am likely not to be the only one feeling this way.
neftanikoff
11/7/2017
11:36
I have checked again the actual price, which is 64.3 to buy down from an actual buy of almost 67p earlier this morning and still the system will not let me do a dummy sell for any amount.
No doubt some of the lth bulls will say no need to worry, eventually the market will catch up with plenty of news in the coming weeks/months and so if you believe in the company go away for the time being. or if youy are that concerned, get phone your broker.
For realism, perhaps it is best to listen to another lth, someone like John Henry and his post 24,763 says that actual deals may not be sealed (or he actually said significant revenues) for possibly another 12 months, are you being a bit pessimitic there John, i hope you are.

neftanikoff
11/7/2017
11:34
Gotta say that I'm also disappointed with the share price reaction today.
Which genuine holder wouldnt be?
I think all those who are in for the long haul are fully loaded and the impatient are selling (inc Mr 10k) Hense the sellers are still firmly in control
Firm figures and fresh deals are needed to change that.
And it will happen. Thats for sure :)
SBTX distribution news wouldnt go amiss either

judijudi
11/7/2017
11:06
End of the year Del Boy.
colinzeal
11/7/2017
11:02
at the end of the year or today colin ?

;o)

onedayrodders
11/7/2017
10:59
I have to say I'm growing slightly impatient here - appreciate Rome wasn't built in a day but it's looking overvalued at £50 million with little to no income or any figures of potential revenue whatsoever.

I'll reassess at the end of the year.

colinzeal
11/7/2017
10:39
Was it not awesome news when the cholesterol trial was completed? How long ago was that? That was in fact September 2015 (RNS sept 29th 2015)and still no sales. Not far off two years later and still waiting.
imnotlong
11/7/2017
10:38
Positive but it's more PR fluff than news that's going to push OPTI forward. What the markets want to see is the colour of money.
rollthedice
11/7/2017
10:32
Awesome news

The response underlines the poor "investor" make up of AIM in general

onedayrodders
11/7/2017
10:22
buywell - you are pathetic!
spike_1
11/7/2017
09:59
''The study used a trained expert panel of ten experienced panellists''


Who do you think paid the 10 experienced panellists ?

What were they experienced in ? dominoes or tiddlywinks ?

buywell3
11/7/2017
09:58
In case you missed it:The study used a TRAINED EXPERT PANEL of ten EXPERIENCED panellists.
parob
Chat Pages: Latest  1050  1049  1048  1047  1046  1045  1044  1043  1042  1041  1040  1039  Older

Your Recent History

Delayed Upgrade Clock